Author Topic: Calif. medical board begins tracking doctors' FDA warning letters, including a doctor treating MS  (Read 62 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest

From MedPage Today (December 14, 2018)--"California Medical Board Begins Tracking Docs' FDA Warning Letters":


https://www.medpagetoday.com/special-reports/states-of-disgrace/76909?xid=nl_mpt_DHE_2018-12-14&eun=g345846d0r&pos=&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202018-12-14%20Resend&utm_term=NL_Daily_DHE_Active


Among the instances cited in the article there is this:


Quote
In June, the California medical board began proceedings against Michael Arata, MD, a physician who had been performing risky and unproven vein-opening procedures on multiple sclerosis patients.Arata had been the subject of three FDA letters dating back to 2012. On June 28, the California board filed a 14-page action that could lead to the revocation or suspension of his license.
« Last Edit: December 19, 2018, 09:45:53 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
117 Views
Last post June 11, 2016, 09:22:55 pm
by agate
1 Replies
241 Views
Last post August 05, 2016, 09:54:38 am
by agate
1 Replies
200 Views
Last post May 18, 2017, 03:36:23 pm
by agate
0 Replies
84 Views
Last post August 04, 2017, 02:13:23 pm
by agate
0 Replies
100 Views
Last post March 30, 2018, 07:14:31 pm
by agate